MNS

📍 Leeds, United Kingdom👥 12 employees💰 Last funded Nov 2025
Biotechnology Research🌐 microneedlesolutions.com
Website LinkedIn
For those who prioritise public health, MNS is the brand of equitable medicine access that delivers seamless, universal healthcare solutions anytime, anywhere, for everyone. At MNS our mission is to reduce health inequalities globally by guaranteeing access to life-saving medication irrespective of location race or gender. We achieve this through our innovative microneedle technology that enables painless, thermally stable and self-administered delivery of almost any therapeutic.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
3
Investor activity2024–2025 · investors recorded per year
2024120252
Recent (last 2y)Earlier
Frequently asked questions
Who invested in MNS?
MNS has 3 investors on record on gritt.io.
When did MNS last raise funding?
The most recent investment in MNS recorded on gritt.io was in November 2025.
What industry is MNS in?
MNS operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MNS based?
MNS is headquartered in Leeds, United Kingdom.